Potential therapeutic interventions for fragile X syndrome

被引：67

作者：

Levenga, Josien ^{[1
]}

de Vrij, Femke M. S. ^{[1
]}

Oostra, Ben A. ^{[1
]}

Willemsen, Rob ^{[1
]}

机构：

[1] Erasmus MC, CBG Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands

来源：

TRENDS IN MOLECULAR MEDICINE | 2010年 / 16卷 / 11期

基金：

美国国家卫生研究院;

关键词：

MENTAL-RETARDATION PROTEIN; METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; MOUSE MODEL; SYNAPTIC PLASTICITY; KNOCKOUT MICE; GABA(A) RECEPTOR; DENDRITIC SPINES; AUDIOGENIC-SEIZURES; SPECTRUM DISORDERS;

D O I：

10.1016/j.molmed.2010.08.005

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Fragile X syndrome (FXS) is caused by a lack of the fragile X mental retardation protein (FMRP); FMRP deficiency in neurons of patients with FXS causes intellectual disability (IQ<70) and several behavioural problems, including hyperactivity and autistic-like features. In the brain, no gross morphological malformations have been found, although subtle spine abnormalities have been reported. FXS has been linked to altered group I metabotropic glutamate receptor (mGluR)-dependent and independent forms of synaptic plasticity. Here, we discuss potential targeted therapeutic strategies developed to specifically correct disturbances in the excitatory mGluR and the inhibitory gamma-aminobutyric (GABA) receptor pathways that have been tested in animal models and/or in clinical trials with patients with FXS.

引用

页码：516 / 527

页数：12

共 110 条

[11] Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model [J].

Bilousova, T. V. ;

Dansie, L. ;

Ngo, M. ;

Aye, J. ;

Charles, J. R. ;

Ethell, D. W. ;

Ethell, I. M. .

JOURNAL OF MEDICAL GENETICS, 2009, 46 (02) :94-102

[12] International Union of Pharmacology.: XXXIII.: Mammalian γ-aminobutyric acidB receptors:: Structure and function [J].

Bowery, NG ;

Bettler, B ;

Froestl, W ;

Gallagher, JP ;

Marshall, F ;

Raiteri, M ;

Bonner, TI ;

Enna, SJ .

PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :247-264

[13] The FMR1 Gene and Fragile X-Associated Tremor/Ataxia Syndrome [J].

Brouwer, J. R. ;

Willemsen, R. ;

Oostra, B. A. .

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2009, 150B (06) :782-798

[14] Phosphorylation influences the translation state of FMRP-associated polyribosomes [J].

Ceman, S ;

O'Donnell, WT ;

Reed, M ;

Patton, S ;

Pohl, J ;

Warren, ST .

HUMAN MOLECULAR GENETICS, 2003, 12 (24) :3295-3305

[15] Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila [J].

Chang, Shuang ;

Bray, Steven M. ;

Li, Zigang ;

Zarnescu, Daniela C. ;

He, Chuan ;

Jin, Peng ;

Warren, Stephen T. .

NATURE CHEMICAL BIOLOGY, 2008, 4 (04) :256-263

[16] Fragile X mice develop sensory hyperreactivity to auditory stimuli [J].

Chen, L ;

Toth, M .

NEUROSCIENCE, 2001, 103 (04) :1043-1050

[17] Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: An observation of initial clinical response and maintenance tolerability [J].

Chez, Michael G. ;

Burton, Quinn ;

Dowling, Timothy ;

Chang, Mina ;

Khanna, Pavan ;

Kramer, Christopher .

JOURNAL OF CHILD NEUROLOGY, 2007, 22 (05) :574-579

[18] Long-term depression in the CNS [J].

Collingridge, Graham L. ;

Peineau, Stephane ;

Howland, John G. ;

Wang, Yu Tian .

NATURE REVIEWS NEUROSCIENCE, 2010, 11 (07) :459-473

[19] Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits [J].

Comery, TA ;

Harris, JB ;

Willems, PJ ;

Oostra, BA ;

Irwin, SA ;

Weiler, IJ ;

Greenough, WT .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) :5401-5404

[20] Pharmacology and functions of metabotropic glutamate receptors [J].

Conn, PJ ;

Pin, JP .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :205-237

← 1 2 3 4 5 6 7 8 9 10 →